CZR - CAESARS ENTMT CORP
This page shows which of the focused investors we track hold CZR and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2019 it was held by 4 managers with an aggregate reported value of $1.9B, which is 0.20% of the combined portfolio.
As of Q4 2019, 4 tracked institutional managers held CZR (CAESARS ENTMT CORP) with an aggregate reported value of $1.9B — 0.20% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades CZR — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2019
- Ticker
- CZR
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Carl Icahn - Icahn Capital Management | 5.94% | - | 114,250,942 | $1.55B |
| 2 | Howard Marks - Oaktree Capital Management | 4.02% | - | 15,250,000 | $207.4M |
| 3 | David Tepper - Appaloosa Management | 3.43% | Reduce -10.3% | 10,050,000 | $136.68M |
| 4 | Lee Ainslie - Maverick Capital | 0.04% | New | 189,501 | $2.58M |
Loading holder history for CZR…